VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 365 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,000 | 0.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,000 | -94.1% | 20,000 | 0.0% | 0.00% | -90.0% |
| Q2 2017 | $17,000 | +142.9% | 20,000 | 0.0% | 0.01% | +150.0% |
| Q1 2017 | $7,000 | -81.1% | 20,000 | 0.0% | 0.00% | -87.5% |
| Q4 2016 | $37,000 | -66.4% | 20,000 | 0.0% | 0.03% | -44.8% |
| Q2 2016 | $110,000 | -54.4% | 20,000 | 0.0% | 0.06% | -70.9% |
| Q1 2016 | $241,000 | – | 20,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |